These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3298482)

  • 1. An unusual case of untreated lepromatous leprosy with rare bacilli: an immunologic follow-up.
    Gelber RH; Mohagheghpour N
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):353-4. PubMed ID: 3298482
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
    Touw J; Stoner GL; Belehu A
    Clin Exp Immunol; 1980 Sep; 41(3):397-405. PubMed ID: 6449337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of levamisole to restore in vitro lymphocyte responsiveness in lepromatous leprosy patients.
    Reitan LJ; Belehu A
    Lepr Rev; 1983 Jun; 54(2):153-5. PubMed ID: 6350777
    [No Abstract]   [Full Text] [Related]  

  • 5. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
    Nath I; Singh R
    Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
    Godal T; Myklestad B; Samuel DR; Myrvang B
    Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
    Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients.
    Robinson P; Mahadevan PR
    J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of leprosy patients and healthy contacts.
    Samuel NM; Neupani K; Loudon J; Samuel S
    Indian J Lepr; 1985; 57(2):288-96. PubMed ID: 3908576
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liberated intracellular pathogen--leprosy model.
    Skinsnes OK; Chang PH; Kuba BA
    Acta Leprol; 1984; 2(2-4):195-210. PubMed ID: 6398581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of T-cell unresponsiveness in leprosy.
    Bach MA; Hoffenbach A; Lagrange PH; Wallach D; Cottenot F
    Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
    Bach MA; Wallach D; Flageul B; Cottenot F
    Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.
    Myrvang B; Godal T; Ridley DS; Fröland SS; Song YK
    Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
    Reitan LJ; Closs O
    Clin Exp Immunol; 1984 Aug; 57(2):315-23. PubMed ID: 6380833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of leprous lymphocytes by leprolin, tuberculin and phytohemagglutinin.
    Han SH; Weiser RS; Lin YC
    Int J Lepr Other Mycobact Dis; 1971; 39(4):789-95. PubMed ID: 4949308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.